EUVIMEDOpdag EUVIMED
Open access

Personalized Support in Hereditary Breast and Ovarian Cancer After Genetic Counseling by the Chatbot-Based GENIE Mobile App: Proof-of-Concept Wizard of Oz Study

Dominik Wolff iD, Thomas Kupka iD, Chiara Reichert iD, Nils Ammon iD, Steffen Oeltze-Jafra iD, Beate Vajen iD

JMIR Formative Research · 2025

DOI: 10.2196/69115 ↗

At a glance

Journal article in JMIR Formative Research, 2025. Written by Dominik Wolff and 5 co-authors. Institution: Peter L. Reichertz Institute for Medical Informatics of TU Braunschweig and Hannover Medical School, Hannover Medical School, Hanover, Germany. Major MEDLINE topics: Mobile Applications, Genetic Counseling, Breast Neoplasms, Ovarian Neoplasms. Cited 5 times so far (Crossref); 41 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The primary aim of genetic counseling at a human genetics center is to empower individuals at risk for hereditary diseases to make informed decisions regarding their health. In Germany, genetic counseling sessions typically last approximately 1 hour and provide highly personalized information by a specialist in human genetics. Despite this, many counselees report a need for additional support following the counseling session.

Objective

This study introduces GENIE, a chatbot-based mobile app designed to assist individuals in the postcounseling phase, with a focus on hereditary breast and ovarian cancer. GENIE delivers expert-curated, personalized information tailored to the user’s health and family circumstances. The content is presented through predefined dialogs between the user and the mobile assistant, aiming to extend the benefits of genetic counseling beyond the initial session.

Methods

A Wizard of Oz study was conducted to evaluate a functional prototype of GENIE. A total of 6 patients with breast cancer, at least 2 years postdiagnosis, participated in the study. Participants were given access to the app for a minimum of 1 week. The evaluation was based on their interaction with GENIE, which was personalized using the details of a fictitious patient. Data collection included semistructured interviews and a 45-item questionnaire to assess usability and content quality.

Results

The analysis of the interview and questionnaire data indicated high usability for GENIE, with a mean System Usability Score of 75.33 (SD 4.13). In total, 5 of the 6 participants used the app daily; 3 participants were willing to pay between US $5 and US $45 as a single purchase, while the other 3 participants agreed that the app should be free for the user and the costs should be directly covered by health insurance. Still, opinions on the app’s appeal were divided. The layout was seen as moderately professional, a bit crowded, and slightly uninspiring. Nevertheless, participants highlighted the credibility and relevance of the content, noting its alignment with the fictitious patient’s scenario. However, areas for improvement were identified, particularly concerning the app’s design. All participants would recommend the app to other affected persons.

Conclusions

The findings suggest that a mobile app like GENIE can provide valuable support to individuals in the postcounseling phase of genetic services. GENIE offers distinct advantages over large language models, as the information it provides is carefully curated by human experts, minimizing the risk of inaccuracies or hallucinations and significantly enhancing the system’s credibility. This study highlights the need to involve the user group as early as possible in the development of a digital health app. Future work will focus on the implementation of a comprehensive personalization engine, redesign of the user interface, and the execution of a large-scale, 2-arm randomized intervention study to validate GENIE’s effectiveness.

Subjects

MeSH terms (MEDLINE)

Mobile ApplicationsGenetic CounselingBreast NeoplasmsOvarian NeoplasmsHumansFemaleMiddle AgedAdultGermanyProof of Concept StudyPrecision MedicineGenerative Artificial Intelligence

Author keywords

HBOCWizard of Oz studyevaluationhereditary breast and ovarian cancerhereditary diseasesmobile health

Authors and institutions

  • Peter L. Reichertz Institute for Medical Informatics of TU Braunschweig and Hannover Medical School, Hannover Medical School, Hanover, Germany.
  • Department for Human Genetics, Hannover Medical School, Carl-Neuberg-Str. 1, Hanover, 30625, Germany, 49 51153280831.

ORCID profiles: Dominik Wolff, Thomas Kupka, Chiara Reichert, Nils Ammon, Steffen Oeltze-Jafra, Beate Vajen

Cite

APA

Wolff, D., Kupka, T., Reichert, C., Ammon, N., Oeltze-Jafra, S., & Vajen, B. (2025). Personalized Support in Hereditary Breast and Ovarian Cancer After Genetic Counseling by the Chatbot-Based GENIE Mobile App: Proof-of-Concept Wizard of Oz Study. JMIR Formative Research. https://doi.org/10.2196/69115

Vancouver

Wolff D, Kupka T, Reichert C, Ammon N, Oeltze-Jafra S, Vajen B. Personalized Support in Hereditary Breast and Ovarian Cancer After Genetic Counseling by the Chatbot-Based GENIE Mobile App: Proof-of-Concept Wizard of Oz Study. JMIR Formative Research. 2025. doi:10.2196/69115

BibTeX
@article{Wolff2025,
  author = {Wolff, Dominik and Kupka, Thomas and Reichert, Chiara and Ammon, Nils and Oeltze-Jafra, Steffen and Vajen, Beate},
  title = {Personalized Support in Hereditary Breast and Ovarian Cancer After Genetic Counseling by the Chatbot-Based GENIE Mobile App: Proof-of-Concept Wizard of Oz Study},
  journal = {JMIR Formative Research},
  year = {2025},
  doi = {10.2196/69115}
}
Start for free →